Pharmacovigilance

Pursuant to the requirements of Art. 184 of the Medicinal Products in Human Medicine Act all medical specialists need to immediately notify the marketing authorization holder and the BDA of any suspected, serious or unexpected adverse drug reaction, regardless of whether the medicinal product is used or not in compliance with the Summary of Product Characteristics.

We hereby declare that the information which you provide with regard to the suspected adverse drug reactions is confidential and the principle of confidentiality will be preserved in processing the information. Please indicate only the patient’s initials in order to preserve his/her anonymity. Mandatory fields are marked with *.

If you are a medical specialist, please click here.

If you are a patient, a relative, a guardian or a friend and you want to report an adverse drug reaction of the use of a Tchaikapharma High Quality Medicines Inc. product, please click here. A medical representative will contact you within two working days to request more detailed information and to further investigate the matter. If you experience problems filling in the information, please contact our specialists:

Tel. 02 9603 725 (24 hours)

E-mail: [email protected]